Urokinase Cisternal Irrigation Therapy for Prevention of Symptomatic Vasospasm After Aneurysmal Subarachnoid Hemorrhage
- 1 June 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (6) , 1256-1262
- https://doi.org/10.1161/01.str.31.6.1256
Abstract
Background and Purpose—Cisternal irrigation therapy with urokinase (UK) was performed in multiple institutions to prevent symptomatic vasospasm. The efficacy and safety of this therapy were evaluated, and the optimal concentration of UK was estimated. Methods—This therapy was performed in 28 patients who underwent surgery within 72 hours of the onset of severe subarachnoid hemorrhage (Fisher’s group 3, CT number [Hounsfield units] >60). After the aneurysm was clipped, irrigation tubes were placed in the Sylvian fissure (inlet) unilaterally and in the prepontine or chiasmatic cistern (outlet). Lactated Ringer’s solution with UK (30, 60, or 120 IU/mL) was infused at a rate of 30 mL/h. The presence of symptomatic vasospasm was evaluated by changes in the clinical symptoms and the presence of a new low-density area on CT scan. Drained irrigation fluid and peripheral blood were examined chronologically to evaluate the fibrinolytic system. Results—Symptomatic vasospasm was observed transiently in 3 cases (10.7%...Keywords
This publication has 17 references indexed in Scilit:
- Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhageSurgical Neurology, 2000
- A Randomized Trial of Intraoperative, Intracisternal Tissue Plasminogen Activator for the Prevention of VasospasmNeurosurgery, 1995
- A Phase II Clinical Trial of Recombinant Human Tissue-type Plasminogen Activator against Cerebral Vasospasm after Aneurysmal Subarachnoid HemorrhageNeurosurgery, 1994
- Vasospasm Prevention with Postoperative Intrathecal Thrombolytic TherapyNeurosurgery, 1994
- A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effectsJournal of Clinical Neuroscience, 1994
- Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activatorJournal of Neurosurgery, 1993
- Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1991
- Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1991
- Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1991
- Prevention of Vasospasm by Clot Removal and Intrathecal Bolus Injection of Tissue-Type Plasminogen Activator: Preliminary ReportNeurosurgery, 1991